Stockscreener 앱 받기
36.43
1.19%
-0.44
시간 외 거래:
36.43
전일 마감가:
$36.87
열려 있는:
$37.34
하루 거래량:
562.19K
Relative Volume:
0.36
시가총액:
$8.27B
수익:
$5.36B
순이익/손실:
$-111.00M
주가수익비율:
-84.78
EPS:
-0.4297
순현금흐름:
$196.00M
1주 성능:
-7.77%
1개월 성능:
-3.70%
6개월 성능:
-12.83%
1년 성능:
-35.84%
1일 변동 폭
$36.31
$37.79
1주일 범위
$36.31
$39.70
52주 변동 폭
$32.45
$61.01
Lineage Inc Stock (LINE) Company Profile
명칭
Lineage Inc
전화
(800) 678-7271
주소
46500 HUMBOLDT DRIVE, NOVI
Compare LINE vs PLD, PSA, EXR, EGP, CUBE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LINE
Lineage Inc
|
36.43 | 8.37B | 5.36B | -111.00M | 196.00M | -0.4297 |
|
PLD
Prologis Inc
|
131.75 | 122.61B | 8.79B | 3.57B | 4.12B | 3.5567 |
|
PSA
Public Storage
|
297.72 | 52.26B | 4.82B | 1.80B | 2.90B | 9.0144 |
|
EXR
Extra Space Storage Inc
|
141.37 | 29.60B | 3.38B | 1.02B | 1.69B | 4.5319 |
|
EGP
Eastgroup Properties Inc
|
187.61 | 10.05B | 721.34M | 257.46M | 404.90M | 4.8717 |
|
CUBE
Cubesmart
|
38.65 | 8.68B | 1.08B | 385.85M | 627.25M | 1.68 |
Lineage Inc Stock (LINE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-13 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-12-18 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-07-01 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-06-23 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-06-23 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-06-12 | 다운그레이드 | BNP Paribas Exane | Neutral → Underperform |
| 2025-05-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-04-10 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-28 | 개시 | Citigroup | Neutral |
| 2025-01-14 | 개시 | Exane BNP Paribas | Neutral |
| 2024-12-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-09-18 | 개시 | CapitalOne | Overweight |
| 2024-09-16 | 개시 | CapitalOne | Overweight |
| 2024-08-19 | 개시 | Deutsche Bank | Hold |
| 2024-08-19 | 개시 | Evercore ISI | In-line |
| 2024-08-19 | 개시 | Goldman | Buy |
| 2024-08-19 | 개시 | JP Morgan | Overweight |
| 2024-08-19 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-19 | 개시 | Mizuho | Neutral |
| 2024-08-19 | 개시 | Morgan Stanley | Overweight |
| 2024-08-19 | 개시 | Piper Sandler | Overweight |
| 2024-08-19 | 개시 | Robert W. Baird | Outperform |
| 2024-08-19 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-19 | 개시 | Truist | Buy |
| 2024-08-19 | 개시 | UBS | Neutral |
| 2024-08-19 | 개시 | Wells Fargo | Equal Weight |
모두보기
Lineage Inc 주식(LINE)의 최신 뉴스
Lineage, Inc. Declares Cash Dividend for the First Quarter of 2026, Payable on April 21, 2026 - marketscreener.com
Lineage raises quarterly dividend by 1% to $0.5325/share - MSN
Lineage, Inc. Declares Increased Dividend for First-Quarter 2026 - The Joplin Globe
Insider Buying: Brian Culley Acquires 15,000 Shares of Lineage C - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Lineage, Inc. (LINE) Investors to Inquire about Securities Investigation - ACCESS Newswire
Lineage, Inc. $LINE Shares Sold by Quantbot Technologies LP - MarketBeat
Top Lineage Insider Makes Bold New Move With Fresh Share Purchase - TipRanks
Capital Research Global Investors Buys 120,616 Shares of Lineage, Inc. $LINE - MarketBeat
Lineage Inc (LINE) Stock Price Down 4.46% on Mar 12 - GuruFocus
Kevin Patrick Marchetti Buys 11,222 Shares of Lineage (NASDAQ:LINE) Stock - MarketBeat
Lineage (LINE) Sees Price Target Raised By Scotiabank | LINE Sto - GuruFocus
Lineage Cell Therapeutics, Inc. Files Form 8-K for At-The-Market Offering – Key Company and Security Information (LCTX, NYSEAMER) 232425 - Minichart
Lineage Cell Therapeutics files prospectus supplement for up to $60 million share offering - Investing.com
Lineage Therap Expands ATM Equity Offering Capacity - TipRanks
West Liberty, Lineage team up on sandwich distribution facility - MEAT+POULTRY
Scotiabank raises Lineage stock price target on cold storage outlook By Investing.com - Investing.com South Africa
Scotiabank raises Lineage stock price target on cold storage outlook - Investing.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lineage, Inc. (LINE) And Encourages Investors to Reach Out - ACCESS Newswire
Lineage, Inc. $LINE Shares Acquired by Barclays PLC - MarketBeat
Lineage (LINE) Price Target Increased to $44 by RBC Capital on Q4 FFO Strength - Finviz
US Market Wrap: Is Klotho Neurosciences Inc gaining market shareGap Down & Daily Technical Forecast Reports - baoquankhu1.vn
Lineage Inc (LINE) Stock Price Down 3.87% on Mar 9 - GuruFocus
H.C. Wainwright Maintains Buy on Lineage Cell Therapeutics (LCTX) Mar 2026 - Meyka
2026-03-08 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lineage, Inc. (LINE) And Encourages Stockholders to Reach Out | NDAQ:LINE | Press Release - Stockhouse
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2025 Earnings Call Transcript - Insider Monkey
Why Lineage Cell Therapeutics Inc. stock could outperform in 2026Portfolio Performance Summary & Free Verified High Yield Trade Plans - Naître et grandir
Lineage, Inc. Earnings Call Balances Progress And Pressure - The Globe and Mail
Can Lineage Cell Therapeutics Inc. stock resist market sell offsQuarterly Growth Report & Long Hold Capital Preservation Plans - Naître et grandir
Lineage Inc (LINE) Trading Down 3.24% on Mar 6 - GuruFocus
Lineage Cell Therapeutics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides B - PharmiWeb.com
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Business Wire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lineage, Inc. (LINE) And Encourages Stockholders to Connect - ACCESS Newswire
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 - Investing News Network
LINE PE Ratio & Valuation, Is LINE Overvalued - Intellectia AI
LCTX SEC FilingsLineage Cell The 10-K, 10-Q, 8-K Forms - Stock Titan
A Look Ahead: Lineage Cell Therapeutics's Earnings Forecast - Benzinga
Lineage (LINE) Is Up 5.1% After Returning to Quarterly Profitability on Flat SalesWhat's Changed - simplywall.st
Analysts Offer Insights on Real Estate Companies: Equity Residential (EQR) and Lineage, Inc. (LINE) - The Globe and Mail
LINE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LINE (NASDAQ: LINE) Form 144 notice: proposed sale of 7,983 shares - Stock Titan
Lineage Point Capital discloses 1.1M shares in TGE Value (BEBE) - Stock Titan
Lineage, Inc. (LINE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Assessing Lineage (NasdaqGS:LINE) Valuation After Q4 Profit Swing And Narrowed Annual Net Loss - simplywall.st
Wells Fargo & Company Forecasts Strong Price Appreciation for Lineage (NASDAQ:LINE) Stock - MarketBeat
Lineage (LINE) Price Target Raised by Wells Fargo to USD 39 | LI - GuruFocus
RBC Raises Price Target on Lineage to $44 From $42, Keeps Outperform Rating - marketscreener.com
Waterfall Asset Management LLC Invests $6.28 Million in Lineage, Inc. $LINE - MarketBeat
Lineage: Cold Storage REIT Still Undervalued Thanks To Near-Term Headwinds (NASDAQ:LINE) - Seeking Alpha
Lineage Cell Therapeutics IncWithdrew CIRM Grant Application Filed In June 2025SEC Filing - TradingView
Artisan Partners Limited Partnership Trims Stock Position in Lineage, Inc. $LINE - MarketBeat
Lineage Inc (LINE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.12%
1.15%
자본화:
|
볼륨(24시간):